GlassScriptPhysician profile
Stephen Sakovich
NPI 1508869769
$807.02
in general payments reported to CMS, 2019-2025
17 companies · $33.30 in 2025
The $33.30 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $14.89 · 2021: $69.28 · 2022: $160 · 2023: $127 · 2024: $76.40 · 2025: $33.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $239.66 | 2019 | |
| Abbvie INC. | $85.55 | 2021-2022 | |
| Avion Pharmaceuticals | $75.04 | 2019 | |
| Minerva Surgical, INC | $71.91 | 2022-2024 | |
| Astellas Pharma US INC | $68.71 | 2023 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $61.61 | 2022-2024 | Omni Hysteroscope, Novasure, Myosure Tissue Removal Device |
| Shield Therapeutics INC | $34.81 | 2024 | |
| Organon LLC | $33.30 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $22.53 | 2022 | |
| Sumitomo Pharma America, INC. | $18.02 | 2023 | Myfembree |
| Exeltis, USA INC. | $16.44 | 2022 | |
| Scynexis, INC. | $15.75 | 2022 | |
| Meditrina | $14.98 | 2022 | |
| Mission Pharmacal Company | $14.89 | 2020 | |
| Coopersurgical, INC. | $11.45 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $11.25 | 2021 | |
| Evofem Biosciences, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sakovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.